NASDAQ
10.66USD
-0.35 (-3.18%)
We have scored 8 news catalysts on ClearPoint Neuro, Inc. (CLPT) over the past 12 months. The biggest single-day move next to one of them came Mar 9, 2026, when CLPT closed +15.4%: “ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?”. Coverage across the window leans mixed (average ticker sentiment +0.02). Most of the impact sits in forward growth expectations and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
319.7M
P/E
—
EPS
—
Beta
1.29
52W range
8.27-30.1
Day range
10.58–10.98
Open
10.85
Prev close
11.01
Volume
490.1K
Avg volume
736.4K
Dividend
0.00
IPO
2012-05-22
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about ClearPoint Neuro, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for CLPT: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
